Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06336122 · ClinicalTrials.gov registry record · NA

OASIS: Peer Support for T2DM in Appalachia (Peer Participant)

A NA study of Diabetes Mellitus, Type 2, sponsored by University of Kentucky.

Recruiting
Registry status
NA
Development phase
76
Enrollment target
2
Study locations

NCT06336122: Recruiting NA study of Diabetes Mellitus, Type 2, sponsored by University of Kentucky.

NCT06336122 is a NA study of Diabetes Mellitus, Type 2 that is actively recruiting participants, run by University of Kentucky. The registered enrollment target is 76 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06336122, a NA study of Diabetes Mellitus, Type 2, is actively recruiting participants, sponsored by University of Kentucky.

RECRUITING
Registry status
NA
Development phase
76 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to compare the effects of peer coaching models in older adults with unmanaged type two diabetes. The main questions it aims to answer are: Are peer coaching models effective at promoting Type 2 Diabetes Mellitus self-management? If effective, which facets of the peer model are most effective? Peer coaches will Undergo peer coach training. Reach out to peer participants on a weekly/biweekly time frame to discuss self-management and goal setting. Retain records of contact, topics discussed, and general notes on interactions. Researchers will compare differences in the frequency of contact, as well as how peer coaches were matched to peer participants to see if efficacy of the intervention is altered between groups.

Primary Outcome

Obtained using point of care assessment

Conditions Studied

Interventions

  • BEHAVIORAL Peer Coach Training - Weekly
  • BEHAVIORAL Peer Coach Training - Biweekly

Study Locations (2)

Kentucky

  • Barren River Area Development District - Bowling Green
  • UK HealthCare - Hazard

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2023-11-20
Est. Completion 2026-03-31
Phase NA
University of Kentucky

54 total trials

What NCT06336122 shows while recruiting

NCT06336122 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Peer Coach Training - Weekly is the first listed.

NCT06336122 reports a single indexed study location in Kentucky.

Frequently Asked Questions

What is clinical trial NCT06336122 about?

NCT06336122 is a clinical study titled "OASIS: Peer Support for T2DM in Appalachia (Peer Participant)". The goal of this clinical trial is to compare the effects of peer coaching models in older adults with unmanaged type two diabetes. The main questions it aims to answer are: Are peer coaching models effective at promoting Type 2 Diabetes Mellitus self-management? If effective, which facets of the ...

What is the current status of trial NCT06336122?

This trial is currently recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2023-11-20. Estimated completion is 2026-03-31.

What conditions does trial NCT06336122 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT06336122?

The interventions under investigation include: Peer Coach Training - Weekly (BEHAVIORAL), Peer Coach Training - Biweekly (BEHAVIORAL).

Who is sponsoring clinical trial NCT06336122?

This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06336122 being conducted?

This trial has 2 study locations across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06336122's enrollment target sits among peer trials

76 223rd of 348 higher than 125 of 348 other Diabetes Mellitus, Type 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02615184 · 76 participants · Phase 2

    A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

  • NCT02821741 · 76 participants · NA

    Effects of External Ear Stimulation on Pain Perception and Mood

  • NCT03019757 · 76 participants

    Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

  • NCT03353584 · 76 participants · NA

    Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06336122, the US trial registry maintained by the National Library of Medicine. NCT06336122 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.